BRCA2 and cancer: Given that the recent reports on TNBC cases describe either no or low frequencies of BRCA2 mutations [3], [4], or refer to very special inbred populations with high founder mutation frequencies [5], or report on incomplete BRCA2 mutation screening approaches [2], we aimed to investigate the BRCA2 mutation frequency in a TNBC cohort of a Southern German population unselected for age of onset and familial aggregation of cancer.